Alto Neuroscience (ANRO) Gains from Investment Securities (2023 - 2025)

Alto Neuroscience has reported Gains from Investment Securities for 3 years, with the latest figure at $41000.0 in Q1 2025.

• Quarterly Gains from Investment Securities fell 83.13% year-over-year to $41000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $95000.0 (up 135.06% YoY) and the FY2024 annual result came in at $297000.0, up 156.57% from the prior year.
• Gains from Investment Securities fell to $41000.0 in Q1 2025 per ANRO's latest filing, from $54000.0 in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $243000.0 in Q1 2024 and troughed at -$226000.0 in Q3 2023.
• A 3-year average of -$26714.3 and a median of -$11000.0 in 2023 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities soared 2309.09% in 2024, then plunged 83.13% in 2025.
• Over 3 years, Gains from Investment Securities stood at -$166000.0 in 2023, then soared by 132.53% to $54000.0 in 2024, then decreased by 24.07% to $41000.0 in 2025.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $41000.0, $54000.0, and $243000.0 for Q1 2025, Q4 2024, and Q1 2024 respectively.